TITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management

Size: px
Start display at page:

Download "TITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management"

Transcription

1 TITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management DATE: 01 June 2010 CONTEXT AND POLICY ISSUES: Sepsis syndrome covers a broad array of illnesses including systemic inflammatory response syndrome (SIRS), sepsis (infection with SIRS), severe sepsis (sepsis with multi-organ dysfunction), and septic shock (severe sepsis with hypotension unresponsive to fluid resuscitation). 1,2 There is no single clinical sign or diagnostic test to confirm diagnosis. 2 Sepsis may occur at any age, in any patient population, and in response to a multitude of microbial pathogens from different anatomical sites. 2 The mortality rate of sepsis is 25% to 80%, depending on illness severity, the number of failed organs and severity of organ failure. 1 Factors which influence outcomes include the age and health status of the patient, and the nature and source of the infection. 1 Early identification and treatment of severe sepsis and septic shock may improve outcomes. 3 Patient risk assessment, screening tools, and scoring systems are helpful in determining the severity of sepsis. 3 Early goal-directed therapy (EGDT) has been shown to reduce mortality rates in clinical trials. 3 EGDT includes early initiation of hemodynamic resuscitation with specified treatment end-points and is most effective if implemented within six hours of arrival at the emergency department (ED). 3 However, one prospective study showed that only 15.8% of patients with severe sepsis were diagnosed correctly by the medical team of an ED. 4 This report reviews the evidence regarding the clinical indicators for the early diagnosis of sepsis and the early treatment of SIRS and sepsis in a pre-hospital setting. RESEARCH QUESTIONS: 1. What is the evidence regarding the clinical indicators for sepsis to assist in an early diagnosis? Disclaimer: The Health Technology Inquiry Service (HTIS) is an information service for those involved in planning and providing health care in Canada. HTIS responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. HTIS responses should be considered along with other types of information and health care considerations. The information included in this response is not intended to replace professional medical advice, nor should it be construed as a recommendation for or against the use of a particular health technology. Readers are also cautioned that a lack of good quality evidence does not necessarily mean a lack of effectiveness particularly in the case of new and emerging health technologies, for which little information can be found, but which may in future prove to be effective. While CADTH has taken care in the preparation of the report to ensure that its contents are accurate, complete and up to date, CADTH does not make any guarantee to that effect. CADTH is not liable for any loss or damages resulting from use of the information in the report. Copyright: This report contains CADTH copyright material. It may be copied and used for non-commercial purposes, provided that attribution is given to CADTH. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners own terms and conditions.

2 2. What are the guidelines regarding the early treatment management of patients identified to have clinical indicators for sepsis or systemic inflammatory response syndrome? METHODS: A focused search (main concept appeared in title or major subject heading) was conducted on key health technology assessment resources, including PubMed, The Cochrane Library (Issue 4, 2010), University of York Centre for Reviews and Dissemination (CRD) databases, ECRI (Health Devices Gold), EuroScan, international health technology agencies, and a focused Internet search. The search was limited to English language articles published between January 1, 2005 and May 4, Filters were applied to limit the retrieval to health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, controlled clinical trials, observational studies, and guidelines. HTIS reports are organized so that the higher quality evidence is presented first. Therefore, systematic reviews are presented first. These are followed by observational studies, and evidence-based guidelines. SUMMARY OF FINDINGS: On the topic of the early diagnosis of sepsis, one systematic review 5 and two observational studies 6,7 were retrieved. Also found were two guidelines that included recommendations on both the diagnosis and the treatment of sepsis in the ED. 8,9 A third set of guidelines included recommendations on the management of sepsis, applicable to both the intensive care unit (ICU) and the non-icu setting. 10 There were no relevant health technology assessments, metaanalyses, randomized controlled trials, or controlled clinical trials retrieved. Systematic review One systematic review on the clinical signs of sepsis in young infants (0 to 2 months old) was identified (Appendix 1, Table 1). 5 The authors conducted a literature search using Medline and found eight studies that met their inclusion criteria. The included studies were communitybased, hospital-based, or a mix of both. No additional information was provided on these studies. Clinical predictors of severe illness in infants included: cyanosis, history of feeding difficulty, breathing difficulty (grunting), respiratory rate greater than 60 beats per minute, abnormal behavior, or a temperature above 38º Celsius. The authors concluded that there was no highly sensitive and highly specific clinical screening tool for the identification of seriously sick infants with sepsis. 5 Observational studies Two observational studies on the diagnosis of sepsis in the ED and out-of-hospital were found and are described in Appendix 1, Table 2. 6,7 Dremsizov et al. examined whether the SIRS criteria, measured at the time of presentation to the ED, could predict the development of severe sepsis, septic shock, or death. 6 SIRS criteria included: body temperature >38º Celsius or <36 º Celsius; heart rate >90 beats/ minute; respiratory rate >20 breaths/ minute, minute ventilation >10 litres/ minute, or Paco 2 <32 mm Hg; and white blood cell count >12,000/ µl or < 4,000/ µl (with >10% immature forms). Physiologic Early Identification of Sepsis 2

3 data were collected in 686 adult patients with clinical and radiologic evidence of pneumonia within 24 hours of presentation to the ED. The predictive value of SIRS was calculated in patients free of severe sepsis on day one of the study (initial presentation to the ED until midnight). A total of 82% of patients had two of the four SIRS criteria on day one. SIRS at presentation was not associated with increased odds of subsequent development of severe sepsis, septic shock, or death. The receiver operating characteristic curve for the discriminative ability of the SIRS criteria to predict severe sepsis, septic shock, or death was less than 0.5, meaning that these criteria were poor predictors of outcomes. The authors concluded that SIRS criteria, measured in the ED, are poorly predictive of severe sepsis, shock, or death in pneumonia patients. 6 Seymour et al. conducted a secondary analysis of a retrospective cohort study to describe the out-of-hospital characteristics of adult patients hospitalized for severe sepsis after being transported to the ED by emergency medical services (EMS) and to determine out-of-hospital factors associated with an increased in serum lactate and sequential organ failure assessment (SOFA) score in the ED. 7 The following definitions were used. Sepsis: a suspected infection in the presence of two or more SIRS criteria. Severe sepsis: sepsis associated with hypoperfusion, hypotension, or organ dysfunction. Septic shock: hypotension despite adequate fluid resuscitation or use of vasoactive agents. The primary and secondary outcomes were the initial serum lactate and the maximum SOFA score measured during the ED stay, respectively. They also studied the association between out-of-hospital factors and the SOFA score. A total of 216 patients were transported to the ED by city EMS. Vital sign abnormalities were common in the out-of-hospital environment, and hypotension occurred in less than 25% of participants. Fortyone percent of subjects presented with serum lactate levels of 4.0 mmol/ L or higher. Lower outof-hospital oxygen saturation, systolic blood pressure, and Glasgow Coma Scale (GCS) score (a score of neurological assessment) were associated with an increase in serum lactate (p<0.03). Maximum SOFA score was greater in patients with out-of-hospital tachypnea, lower blood pressure, lower GCS, and lower oxygen saturation (p<0.05). The authors concluded that out-of-hospital hypotension, hypoxemia, and altered mental status were uncommon in patients who were hospitalized with severe sepsis. Further, routinely measured, out-of-hospital clinical variables were associated with greater serum lactate levels and SOFA scores upon arrival to the ED. 7 Guidelines and recommendations Nguyen et al.: Published in 2006, a group of American physicians representing various medical specialties created guidelines for the management of severe sepsis and septic shock in the ED. 8 Their objective was to provide an independent clinical review on contemporary management strategies for ED patients with severe sepsis and septic shock. Although they did not specify the literature search methods used, they did state that the recommendations were developed through consensus and that these were graded according to previously published criteria by D.L. Sackett (Appendix 2). The authors stated that studies on the diagnostic value of laboratory tests, and clinical findings among a broad-based ED population do not exist; that the hallmark finding of infection is fever; and that SIRS criteria, ill appearance, or hypotension should trigger an expedited ED evaluation for presence of sepsis. (Grade E) Several recommendations were made for the ED treatment of adult patients with severe sepsis or septic shock: Early Identification of Sepsis 3

4 1) institute early goal directed therapy within six hours of presentation; includes fluid resuscitation, vasoactive agents, blood transfusion, inotrope therapy with sedation, paralysis, and intubation (Grade B) 2) give appropriate (Grade D) and timely (Grade E) antimicrobial therapy 3) eradicate the source of the infection (Grade E) 4) consider activated protein C (Grade B) 5) consider low-dose corticosteroids (Grade C) 6) give low tidal volume mechanical ventilation (Grade B). 8 Green et al.: The Canadian Association of Emergency Physicians formulated guidelines (2008) for the optimal management of severe sepsis applicable to Canadian emergency departments. 9 Their objective was to review key management principles of severe sepsis for Canadian emergency physicians. Their literature search methods included a PubMed search and additional searches by individual members. The evidence was graded according to the Oxford Centre for Evidence-based Medicine (Appendix 2). With respect to diagnosis, this was identified as an area where a lack of objective data exists and hence, no recommendations were provided. For the treatment of severe sepsis, several recommendations were made: 1) endotracheal intubation should be instituted when required for airway protection, support of oxygenation or assisted ventilation (Grade D); patients unresponsive to fluid resuscitation should have central venous access (Grade D); the internal jugular or subclavian veins are preferred (Grade D) 2) fluid resuscitation should be initiated immediately (Grade B) using Ringer s lactate, normal saline or albumin (Grade D) 3) vasopressors ( norepinephrine and dopamine, Grade C) should be administered through a central line (not graded) after adequate volume resuscitation to maintain blood pressure and organ perfusion (Grade B) 4) inotropes (dobutamine, Grade D) should be used to maintain central venous oxygen saturation over 70% (Grade D) and adequate cardiac output (Grade D) in volume-replete septic patients who have adequate blood pressure 5) patients should receive antibiotics against all likely pathogens (Grade B) as soon as possible (Grade C) 6) sources of infection should be controlled or eliminated (Grade D) 7) limited data is available on the use of activated protein C in the ED; activated protein C infusions may be considered in adult patients with severe sepsis (Grade B) 8) low dose corticosteroids may be considered in hemodynamically unstable patients who do not respond to volume resuscitation and vasopressor infusion (Grade D) 9) blood transfusions may be considered in patients with early septic shock (Grade B) 10) ventilation may be used (Grade D). 9 Dellinger et al.: The Surviving Sepsis Campaign guidelines were updated from guidelines originally published in 2001 and updated in The objectives of the guidelines were to provide guidance for the clinician caring for a patient with severe sepsis or septic shock. The recommendations were appropriate to patients across the spectrum of acute care, including the non-icu setting. A separate Medline search was used for each defined research question, Early Identification of Sepsis 4

5 spanning the years 1991 to Representatives of associations and societies from various countries formed subgroups charged with providing an update to specific areas. The process included a modified Delphi method, a consensus conference, and other meetings. The quality of the evidence was judged by Grades of Recommendation, Assessment, Development and Evaluation (GRADE) criteria (Appendix 2). The guidelines did not address the early diagnosis of sepsis. Treatment recommendations for adults included: Limitations 1) initiate resuscitation immediately (within first six hours) in patients with hypotension or elevated serum lactate >4 mmol/ L (Grade C) 2) begin intravenous antibiotics within the first hour of recognizing severe sepsis (Grade D) or septic shock (Grade B) 3) use on or more agents active against likely bacterial/ fungal pathogens and with good penetration in presumed source (Grade B) 4) site of infection should be established as early as possible (Grade C) and within first six hours of presentation (Grade D) 5) implement source control measures (Grade C) 6) fluid-resuscitate using crystalloids or colloids (Grade B) 7) give norepinephrine or dopamine centrally administered as the initial vasopressor of choice (Grade C) 8) use dobutamine in patients with myocardial dysfunction (Grade C) 9) consider intravenous hydrocortisone for septic shock when hypotension remains poorly responsive to adequate fluid resuscitation (Grade C) 10) consider activated protein C in patients with sepsis-induced organ dysfunction (Grade B). 10 The included systematic review is limited by the fact that the search methods for identifying studies were not comprehensive; the authors did not clearly describe the criteria used for selecting the included studies; and they did not describe the study designs and their quality. Although both observational studies described themselves as cohort studies, the authors reanalyzed the data of a group of patients that were part of a larger study. Because all patients recruited into the studies had SRIS or sepsis, these sub-studies appeared to be more like large case series. Case series should be seen as hypothesis generating rather than studies from which to derive firm conclusions. The guidelines were generally well prepared, although one guideline did not specify the literature search methods used. 8 CONCLUSIONS AND IMPLICATIONS FOR DECISION OR POLICY MAKING: One systematic review, two observational studies, and three guidelines that met our selection criteria were identified. Early diagnosis of sepsis: One systematic review 5 of eight studies conducted in infants 0 to 2 months reported that signs of cyanosis, feeding difficulty, grunting, respiratory rate greater than 60 beats per minute, abnormal behavior, or fever may predict sepsis in this population. Early Identification of Sepsis 5

6 Two observational studies gave conflicting results. In one, the presence of SIRS in adult patients with community-acquired pneumonia presenting to the ED was a poor predictor of whether or not severe sepsis or septic shock would develop. 6 In another observational study, adult patients who developed severe sepsis while in the ED had vital signs abnormalities and SIRS before arriving to the hospital. 7 Two of the three sets of guidelines addressed the diagnosis of sepsis in the ED. Whereas one guideline could not make a recommendation due to a lack of evidence, 9 the other guideline based its recommendation on expert opinion. It stated that clinicians should suspect sepsis in patients with SIRS, ill appearance, or hypotension. 8 Based on the findings above, we cannot make a definitive conclusion about the clinical signs that may best assist in the early diagnosis of sepsis. Early treatment of sepsis: The treatment of sepsis in a non-icu setting or in the ED was addressed in three sets of guidelines. All had similar sets of recommendations. These included initiating fluid resuscitation immediately, administering medications such antibiotics, vasopressors, inotropes, low-dose corticosteroids, and activated protein C, and controlling the source of the infection. These recommendations were based on evidence ranging from large randomized controlled trials to expert opinions. PREPARED BY: Health Technology Inquiry Service htis@cadth.ca Tel: Early Identification of Sepsis 6

7 REFERENCES: 1. Nee PA. Critical care in the emergency department: severe sepsis and septic shock. Emerg Med J [Internet] Sep [cited 2010 May 6];23(9): Available from: 2. Opal SM. Severe sepsis and septic shock: defining the clinical problem. Scand J Infect Dis. 2003;35(9): Rivers EP, Ahrens T. Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation. Crit Care Clin Jul;24(3 Suppl):S Rezende E, Silva JM Jr, Isola AM, Campos EV, Amendola CP, Almeida SL. Epidemiology of severe sepsis in the emergency department and difficulties in the initial assistance. Clinics [Internet] Aug [cited 2010 May 6];63(4): Available from: 5. Newton O, English M. Young infant sepsis: aetiology, antibiotic susceptibility and clinical signs. Trans R Soc Trop Med Hyg [Internet] Oct [cited 2010 May 6];101(10): Available from: 6. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest [Internet] Apr [cited 2010 May 7];129(4): Available from: 7. Seymour CW, Band RA, Cooke CR, Mikkelsen ME, Hylton J, Rea TD, et al. Out-ofhospital characteristics and care of patients with severe sepsis: a cohort study. J Crit Care Apr Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med [Internet] Jul [cited 2010 May 7];48(1): Available from: 9. Green RS, Djogovic D, Gray S, Howes D, Brindley PG, Stenstrom R, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM [Internet] Sep [cited 2010 May 7];10(5): Available from: Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: Intensive Care Med [Internet] Jan [cited 2010 May 6];34(1): Available from: Early Identification of Sepsis 7

8 APPENDIX 1: Findings Table 1: Systematic review First Literature author search Newton, Medline 1990 to March 2006; Cochrane Library Issue 2, 2006; bibliographies of retrieved articles; reference collection of experts; no language restrictions Inclusion criteria, methods studies with primary data on clinical signs predicting severe illness in infants less than 2 months; titles and abstracts examined by 2 reviewers; quality of studies assessed using Oxford Centre for Evidence-Based Medicine, but not reported Outcomes clinical signs for predicting severe illness in infants Results n=8 studies found signs: -cyanosis -history of feeding difficulty -breathing difficulty (grunting) -respiratory rate >60 beats per minute -abnormal behaviour -temperature >38ºC Table 2: Clinical indicators for the early diagnosis of sepsis First author Study design Population Outcomes Results Dremsizov, subgroup analysis of a retrospective, multi-site, cohort study adult patients 18 years old, with CAP diagnosed within 24 hours of presentation to ED n= 686 mean age: 54.4 years male gender: 49.1% predictive value of SIRS (for patients free of severe sepsis on initial presentation at ED) 562/ 686 (82%) patients with 2 of 4 SIRS criteria on day one severe sepsis: -OR 0.65 (95%CI: 0.38, 1.11), p=0.10 -ROC 0.46 (95%CI: 0.40, 0.53) septic shock: -OR 0.80 (95%CI: 0.23, 3.62), p=0.74 -ROC 0.48 (95%CI: 0.33, 0.64) death: -OR 0.65 (95%CI: 0.24, 2.04), p=0.41 -ROC 0.46 (95%CI: 0.33, 0.60) Early Identification of Sepsis 8

9 Seymour, secondary analysis of a retrospective cohort study January 2005 to December 2006 adult patients with severe sepsis and septic shock as well as being transported to the ED by emergency medical services primary: initial serum lactate median serum lactate: 3.0 mmol/ L (IQR: 2.0 mmol/ L to 5.0 mmol/ L); 41% of subjects presented with initial lactate levels of 4.0 mmol/ L n=216 mean age, standard deviation: 61±17 male gender: 54% CAP=community-acquired pneumonia; CI=confidence interval; ED=emergency department; IQR=interquartile range; OR=odds ratio; ROC=receiver operating characteristic; SIRS=systemic inflammatory response syndrome Early Identification of Sepsis 9

10 APPENDIX 2: Grades of recommendations Nguyen et al.: graded according to previously published criteria by D.L. Sackett 8 Grade A: supported by at least two level I investigations (large randomized trials with clear cut results; low risk of false-positive error or false-negative error) Grade B: supported by one level I investigation (large randomized trial with clear cut results; low risk of false-positive error or false-negative error) Grade C: supported by level II investigations only (small, randomized trials with uncertain results; moderate to high risk false-positive error or false-negative error) Grade D: supported by at least one level III investigation (nonrandomized, contemporaneous controls) Grade E: supported by level IV or V evidence (nonrandomized, historical controls, case series, uncontrolled studies, and expert opinion) 8 Green et al.: graded according to the Oxford Centre for Evidence-based Medicine 9 Grade A: level 1 studies (systematic review of randomized controlled trials or individual randomized controlled trial with narrow confidence interval) Grade B: level 2 studies (systematic review of cohort studies or individual cohort study or low quality randomized controlled trials or outcomes research) or level 3 studies (systematic review of case-control studies or individual case-control study), or extrapolations from level 1 studies Grade C: level 4 studies (case-series or poor quality cohort and case-control studies), or extrapolation from level 2 or 3 studies Grade D: level 5 evidence (expert opinion) or troublingly inconsistent or inconclusive studies of any level 9 Dellinger et al.: graded according to Grades of Recommendation, Assessment, Development and Evaluation (GRADE) criteria 10 Grade A: RCT Grade B: downgraded RCT or upgraded observational studies Grade C: well-done observational studies Grade D: case series or expert opinions (p19) 10 Early Identification of Sepsis 10

TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety

TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety DATE: 1 April 2010 CONTEXT AND POLICY ISSUES: The prevalence of epilepsy ranges from 0.5% to 1%, 1,2 and

More information

TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines

TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines DATE: 11 April 2014 CONTEXT AND POLICY ISSUES Traumatic brain

More information

Sepsis Management: Past, Present, and Future

Sepsis Management: Past, Present, and Future Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe

More information

Title: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review

Title: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review Title: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review Date: 14 February 2008 Context and policy issues: Anemia is a complication of chronic diseases and commonly occurs in

More information

DATE: 09 December 2009 CONTEXT AND POLICY ISSUES:

DATE: 09 December 2009 CONTEXT AND POLICY ISSUES: TITLE: Tiotropium Compared with Ipratropium for Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease: A Review of the Clinical Effectiveness DATE: 09 December 2009 CONTEXT AND POLICY

More information

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health What the ED clinician needs to know about SEPSIS - 3 Anna Morgan Consultant EM Barts Health Aims: (1) To review the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (2)

More information

TITLE: Probenecid Dosing When Given with Cefazolin: Guidelines and Clinical Effectiveness

TITLE: Probenecid Dosing When Given with Cefazolin: Guidelines and Clinical Effectiveness TITLE: Probenecid Dosing When Given with Cefazolin: Guidelines and Clinical Effectiveness DATE: 21 November 2008 RESEARCH QUESTIONS: 1. What is the evidence for the clinical effectiveness of the 1g dose

More information

DATE: 17 July 2012 CONTEXT AND POLICY ISSUES

DATE: 17 July 2012 CONTEXT AND POLICY ISSUES TITLE: Sterile Pre-filled Saline Syringes for Acute Care Patients: A Review of Clinical Evidence, Cost-effectiveness, Evidence-based Guidelines, and Safety DATE: 17 July 2012 CONTEXT AND POLICY ISSUES

More information

BC Sepsis Network Emergency Department Sepsis Guidelines

BC Sepsis Network Emergency Department Sepsis Guidelines The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to

More information

TITLE: Dose of Electrical Current for Biphasic Defibrillators for Synchronous Cardioversion in Patients with Tachyarrhythmia: Guidelines

TITLE: Dose of Electrical Current for Biphasic Defibrillators for Synchronous Cardioversion in Patients with Tachyarrhythmia: Guidelines TITLE: Dose of Electrical Current for Biphasic Defibrillators for Synchronous Cardioversion in Patients with Tachyarrhythmia: Guidelines DATE: 5 May 2009 RESEARCH QUESTION: What recommendations exist for

More information

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness DATE: 08 October 2009 CONTEXT AND POLICY ISSUES: Poly-drug abuse is

More information

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care

More information

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated

More information

TITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness

TITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness TITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness DATE: 27 August 2014 CONTEXT AND POLICY ISSUES Mental illness, including major depressive episode,

More information

OHSU. Update in Sepsis

OHSU. Update in Sepsis Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin

More information

TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations

TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations DATE: 29 September 2010 CONTEXT AND POLICY ISSUES: Atrial fibrillation (AF) is the irregular, rapid beating of the

More information

TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines

TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines DATE: 25 September 2015 RESEARCH QUESTIONS 1. What is the

More information

Sepsis: Identification and Management in an Acute Care Setting

Sepsis: Identification and Management in an Acute Care Setting Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES

More information

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage

More information

Early Goal-Directed Therapy

Early Goal-Directed Therapy Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The

More information

TITLE: Hyperbaric Oxygen Therapy for Autism: A Review of the Clinical and Cost- Effectiveness

TITLE: Hyperbaric Oxygen Therapy for Autism: A Review of the Clinical and Cost- Effectiveness TITLE: Hyperbaric Oxygen Therapy for Autism: A Review of the Clinical and Cost- Effectiveness DATE: 19 November 2009 CONTEXT AND POLICY ISSUES: Autism is a pervasive developmental disorder characterized

More information

TITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines

TITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines TITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines DATE: 11 August 2014 CONTEXT AND POLICY ISSUES Patient-controlled analgesia

More information

DATE: 04 April 2012 CONTEXT AND POLICY ISSUES

DATE: 04 April 2012 CONTEXT AND POLICY ISSUES TITLE: Procedure Site Bleeding Complications Following Percutaneous Coronary Interventions or Angioplasty: A Review of Clinical Evidence and Guidelines DATE: 04 April 2012 CONTEXT AND POLICY ISSUES Percutaneous

More information

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures Sepsis Update: Focus on Early Recognition and Intervention Jessie Roske, MD October 2017 Disclosures I have no actual or potential conflict of interest in relation to this program/presentation. I will

More information

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of

More information

TITLE: Closed Catheter Systems for Prevention of Urinary Tract Infections: A Review of the Clinical Effectiveness

TITLE: Closed Catheter Systems for Prevention of Urinary Tract Infections: A Review of the Clinical Effectiveness TITLE: Closed Catheter Systems for Prevention of Urinary Tract Infections: A Review of the Clinical Effectiveness DATE: 24 November 2008 CONTEXT AND POLICY ISSUES: Urinary tract infections (UTI) are the

More information

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available

More information

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018 Current State of Pediatric Sepsis Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018 Objectives Review the history of pediatric sepsis Review the current definition of pediatric sepsis Review triage

More information

Title: Re-using the Canister Portion of Metered Dose Inhalers in a Hospital Setting: Clinical Review of Safety, Cost-Effectiveness and Guidelines

Title: Re-using the Canister Portion of Metered Dose Inhalers in a Hospital Setting: Clinical Review of Safety, Cost-Effectiveness and Guidelines Title: Re-using the Canister Portion of Metered Dose Inhalers in a Hospital Setting: Clinical Review of Safety, Cost-Effectiveness and Guidelines Date: 16 June 2008 Context and policy issues: A metered

More information

Sepsis: What Is It Really?

Sepsis: What Is It Really? Sepsis: What Is It Really? Steven D. Burdette, MD, FIDSA, FACP Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship for Premier Health and Miami

More information

Sepsis and Septic Shock: New Definitions for Adults

Sepsis and Septic Shock: New Definitions for Adults PL Detail-Document #320424 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER April 2016 Sepsis and Septic

More information

TITLE: Type of Thermometer for Inpatients: Clinical-Effectiveness and Guidelines

TITLE: Type of Thermometer for Inpatients: Clinical-Effectiveness and Guidelines TITLE: Type of Thermometer for Inpatients: Clinical-Effectiveness and Guidelines DATE: 28 May 2009 RESEARCH QUESTIONS: 1. What is the clinical-effectiveness of tympanic, temporal, oral, and rectal thermometers

More information

TITLE: Vacuum Boards for Spinal Motion Restriction: Clinical Effectiveness

TITLE: Vacuum Boards for Spinal Motion Restriction: Clinical Effectiveness TITLE: Vacuum Boards for Spinal Motion Restriction: Clinical Effectiveness DATE: 14 October 2008 RESEARCH QUESTION: What are the clinical benefits and harms of using vacuum boards for spinal motion restriction?

More information

Staging Sepsis for the Emergency Department: Physician

Staging Sepsis for the Emergency Department: Physician Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected

More information

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital The Ever Changing World of Sepsis Management Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital COI Disclosures No financial interests to disclose Learning Objectives Review the evolution

More information

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Evidence-Based. Management of Severe Sepsis. What is the BP Target? Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco

More information

Title: Scoop Stretcher for Restriction of Spinal Motion: Clinical Effectiveness

Title: Scoop Stretcher for Restriction of Spinal Motion: Clinical Effectiveness Title: Scoop Stretcher for Restriction of Spinal Motion: Clinical Effectiveness Date: 28 May 2008 Research question: What is the evidence for the clinical effectiveness of a scoop stretcher to restrict

More information

Sepsis Management Update 2014

Sepsis Management Update 2014 Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma

More information

Nothing to disclose 9/25/2017

Nothing to disclose 9/25/2017 Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain

More information

Sepsis Awareness and Education

Sepsis Awareness and Education Sepsis Awareness and Education Meets the updated New York State Department of Health (NYSDOH) requirements for Infection Control and Barrier Precautions coursework Element VII: Sepsis Awareness and Education

More information

9/25/2017. Nothing to disclose

9/25/2017. Nothing to disclose Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain

More information

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust The Septic Patient Dr Arunraj Navaratnarajah Renal SpR Imperial College NHS Healthcare Trust Objectives of this session Define SIRS / sepsis / severe sepsis / septic shock Early recognition of Sepsis The

More information

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%

More information

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness Service Line: Rapid Response Service Version: 1.0 Publication Date: August

More information

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis

More information

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING Christopher Hunter, MD, PhD, FACEP Director, Health Services Department Associate Medical Director, Orange County EMS System Medical Director, Orlando Health

More information

Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review

Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review Date: 07 April 2008 Context and policy issues: Abdominal aortic aneurism (AAA)

More information

Inflammatory Statements

Inflammatory Statements Inflammatory Statements Using ETCO 2 Analysis in Sepsis Syndromes George A. Ralls M.D. Orange County EMS System Sepsis Sepsis Over 750,000 cases annually Expected growth of 1.5% per year Over 215,000 deaths

More information

No conflicts of interest to disclose

No conflicts of interest to disclose No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,

More information

TITLE: Critical Incident Stress Debriefing for First Responders: A Review of the Clinical Benefit and Harm

TITLE: Critical Incident Stress Debriefing for First Responders: A Review of the Clinical Benefit and Harm TITLE: Critical Incident Stress Debriefing for First Responders: A Review of the Clinical Benefit and Harm DATE: 12 February 2010 CONTEXT AND POLICY ISSUES: Critical incident stress debriefing (CISD) is

More information

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017 INTENSIVE CARE MEDICINE CPD EVENING Dr Alastair Morgan Wednesday 13 th September 2017 WHAT IS NEW IN ICU? (RELEVANT TO ANAESTHETISTS) Not much! SURVIVING SEPSIS How many deaths in England were thought

More information

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Key Points. Angus DC: Crit Care Med 29:1303, 2001 Sepsis Key Points Sepsis is the combination of a known or suspected infection and an accompanying systemic inflammatory response (SIRS) Severe sepsis is sepsis with acute dysfunction of one or more organ

More information

TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines

TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines DATE: 08 May 2014 CONTEXT AND POLICY ISSUES Electroconvulsive therapy (ECT) is a treatment that

More information

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the

More information

Initial Resuscitation of Sepsis & Septic Shock

Initial Resuscitation of Sepsis & Septic Shock Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known

More information

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London IV fluid administration in sepsis Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London The talk What is septic shock? What are the recommendations? What is the evidence? Do we follow

More information

John Park, MD Assistant Professor of Medicine

John Park, MD Assistant Professor of Medicine John Park, MD Assistant Professor of Medicine Faculty photo will be placed here park.john@mayo.edu 2015 MFMER 3543652-1 Sepsis Out with the Old, In with the New Mayo School of Continuous Professional Development

More information

Date: 23 June Context and policy issues:

Date: 23 June Context and policy issues: Title: Basiliximab for Immunosuppression During a Calcineurin Inhibitor Holiday in Renal Transplant Patients with Acute Renal Dysfunction: Guidelines for Use and a Clinical and Cost-Effectiveness Review

More information

SEPSIS SYNDROME

SEPSIS SYNDROME INTRODUCTION Sepsis has been defined as a life threatening condition that arises when the body s response to an infection injures its own tissues and organs. Sepsis may lead to shock, multiple organ failure

More information

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare

More information

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Steven Q Simpson, MD, FCCP, FACP Professor of Medicine Division of Pulmonary and Critical Care University of Kansas Disclosures No

More information

UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center

UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center ShannonFry@fhshealth.org DISCLOSURE I have no financial relationships to disclose OBJECTIVES

More information

TITLE: Australian Sheepskins for the Management of Pressure Ulcers: A Review of the Clinical-Effectiveness, Cost-Effectiveness, and Guidelines

TITLE: Australian Sheepskins for the Management of Pressure Ulcers: A Review of the Clinical-Effectiveness, Cost-Effectiveness, and Guidelines TITLE: Australian Sheepskins for the Management of Pressure Ulcers: A Review of the Clinical-Effectiveness, Cost-Effectiveness, and Guidelines DATE: 21 July 2009 CONTEXT AND POLICY ISSUES: Pressure ulcers,

More information

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Surviving Sepsis Campaign Guidelines 2012 & Update for 2015 David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Louis Be appropriately aggressive the longer one delays aggressive metabolic

More information

Early Recognition and Timely Management of Sepsis Amid Changes in Definitions

Early Recognition and Timely Management of Sepsis Amid Changes in Definitions Early Recognition and Timely Management of Sepsis Amid Changes in Definitions Tze Shien Lo, MD, FACP Chief, Infectious Disease Service Fargo VA Medical Center Professor of Medicine UND School of Medicine

More information

Updates in Sepsis 2017

Updates in Sepsis 2017 Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials

More information

Early-goal-directed therapy and protocolised treatment in septic shock

Early-goal-directed therapy and protocolised treatment in septic shock CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:

More information

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. SEPSIS: IT ALL BEGINS WITH INFECTION Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. Worth 1 2 3 OBJECTIVES Review the new Sepsis 3 definitions of sepsis

More information

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program Sepsis 3 & Early Identification David Carlbom, MD Medical Director, HMC Sepsis Program Disclosures I have no relevant financial relationships with a commercial interest and will not discuss off-label use

More information

Title: Ultrasound for Breast Cancer Screening: Clinical Effectiveness. Date: 4 January Context and policy issues:

Title: Ultrasound for Breast Cancer Screening: Clinical Effectiveness. Date: 4 January Context and policy issues: Title: Ultrasound for Breast Cancer Screening: Clinical Effectiveness Date: 4 January 2008 Context and policy issues: It is estimated that 22,300 women will be diagnosed with breast cancer and approximately

More information

Sepsis. Current Dilemmas in Diagnosing Sepsis. Chapter 2

Sepsis. Current Dilemmas in Diagnosing Sepsis. Chapter 2 Chapter 2 Current Dilemmas in Diagnosing Derek Braun Derek Braun, Banner Health, 2901 N. Central Ave. Ste 180, Phoenix, AZ 85012 Email: derek.braun@bannerhealth.com Abbreviations: APACHE : Acute Physiology,

More information

TITLE: Memantine in Combination with Cholinesterase Inhibitors for Alzheimer s Disease: Clinical Effectiveness

TITLE: Memantine in Combination with Cholinesterase Inhibitors for Alzheimer s Disease: Clinical Effectiveness TITLE: Memantine in Combination with Cholinesterase Inhibitors for Alzheimer s Disease: Clinical Effectiveness DATE: 30 October 2008 RESEARCH QUESTION: What is the evidence for using memantine in combination

More information

Guidelines are the Future of Sepsis Management Pro

Guidelines are the Future of Sepsis Management Pro Guidelines are the Future of Sepsis Management Pro R. Phillip Dellinger MD, MCCM Professor and Chair of Medicine Director Adult Health Institute Senior Critical Care Attending Camden NJ USA Objectives

More information

TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness

TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness DATE: 13 January 2015 CONTEXT AND POLICY ISSUES According to the World health Organization, the

More information

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS R. Phillip Dellinger MD, MSc, MCCM Professor and Chair of Medicine Cooper Medical School of Rowan University Chief of Medicine Cooper University Hospital

More information

TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines

TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines DATE: 17 January 2014 CONTEXT AND POLICY ISSUES Obstructive sleep apnea (OSA) is a common

More information

Timing of Vasopressors in Septic Shock: How Soon is Too Soon?

Timing of Vasopressors in Septic Shock: How Soon is Too Soon? Timing of Vasopressors in Septic Shock: How Soon is Too Soon? Anand Kumar, MD Sections of Critical Care Medicine and Infectious Diseases Professor of Medicine, Medical Microbiology and Pharmacology University

More information

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM 1 Surviving Sepsis Brian Woodcock MBChB MRCP FRCA FCCM 2 Disclosures No conflicts of interest 3 Sepsis Principles of management of septic shock in the operating room "Surviving Sepsis" guidelines 4 Add-on

More information

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa The syndrome formerly known as Severe Sepsis James Rooks MD Coordinator of critical care education OU College of Medicine, Tulsa Disclosures I have no actual or practical conflicts of interest in relation

More information

SEPSIS 2015 DISCLOSURES FINANCIAL DISCLOSURES 9/1/2015. William M. Johnson, MD Nebraska Pulmonary Specialties. William Johnson

SEPSIS 2015 DISCLOSURES FINANCIAL DISCLOSURES 9/1/2015. William M. Johnson, MD Nebraska Pulmonary Specialties. William Johnson SEPSIS 2015 William M. Johnson, MD Nebraska Pulmonary Specialties 1 DISCLOSURES William Johnson No financial interests related to this presentation 2 FINANCIAL DISCLOSURES I do however have 3 children

More information

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018 Tailored Volume Resuscitation in the Critically Ill is Achievable Heath E Latham, MD Associate Professor Fellowship Program Director Pulmonary and Critical Care Objectives Describe the goal of resuscitation

More information

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital R2R: Severe sepsis/septic shock Surat Tongyoo Critical care medicine Siriraj Hospital Diagnostic criteria ACCP/SCCM consensus conference 1991 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

More information

towards early goal directed therapy

towards early goal directed therapy Paediatric Septic Shock- towards early goal directed therapy Elliot Long Paediatric Acute Care 2011 Conference Outline Emergency Department Rivers Protocol (EGDT) ACCM Sepsis Protocol Evidence Barriers

More information

Updates in Emergency Department Management of Sepsis

Updates in Emergency Department Management of Sepsis Resident Journal Review Updates in Emergency Department Management of Sepsis Authors: Eli Brown, MD; Allison Regan, MD; Kaycie Corburn, MD; Jacqueline Shibata, MD Edited by: Jay Khadpe, MD FAAEM; Michael

More information

Title: IV Colloid Plasma Volume Expanders for Hypovolemia. Date: May 15, 2007

Title: IV Colloid Plasma Volume Expanders for Hypovolemia. Date: May 15, 2007 Title: IV Colloid Plasma Volume Expanders for Hypovolemia Date: May 15, 2007 Research question: What is the clinical effectiveness of intravenous colloid plasma volume expanders for patients with profound

More information

Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department

Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department Clin Exp Emerg Med 2014;1(1):35-40 http://dx.doi.org/10.15441/ceem.14.012 Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department

More information

Presented by: Indah Dwi Pratiwi

Presented by: Indah Dwi Pratiwi Presented by: Indah Dwi Pratiwi Normal Fluid Requirements Resuscitation Fluids Goals of Resuscitation Maintain normal body temperature In most cases, elevate the feet and legs above the level of the heart

More information

Management of Severe Sepsis:

Management of Severe Sepsis: Management of Severe Sepsis: Update from the Surviving Sepsis Campaign Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University NONE Disclosures Review evidence-based international sepsis

More information

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated Update on Surviving Sepsis 2008 Objectives Epidemiology of Sepsis Definition of Sepsis and Septic Shock Review Guidelines for Resuscitation Dx: Lactate, t cultures, SVO2 Tx: EGDT, timing/choice of abx,

More information

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018 Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018 Objectives 1. To identify the symptom of severe sepsis and septic shock syndrome.

More information

Sepsis clinical evolution: Understand essential challenges to developing effective queries

Sepsis clinical evolution: Understand essential challenges to developing effective queries Understand essential challenges to developing effective queries ADVICE FROM THE ACDIS REGULATORY COMMITTEE Summary: This paper provides a timeline of the various sepsis definitions and their implications

More information

Methodological co-investigators

Methodological co-investigators Protocolised Management In Sepsis: A multicentre randomised controlled trial of the clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock Methodological

More information

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Presenters Mark Blaney, RN Regional Nurse Educator CHI Franciscan Health Karen Lautermilch Director, Quality & Performance

More information

Chapter 5: Sepsis Stephen Lo

Chapter 5: Sepsis Stephen Lo Chapter 5: Sepsis Stephen Lo Introduction Sepsis and its consequence are the bread and butter of intensive care medicine and management of it is time critical. This chapter will discuss the definitions,

More information

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital SHOCK Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital 1 Definition Shock is an acute, complex state of circulatory dysfunction

More information

This report will provide a review on the comparative clinical effectiveness and safety between intranasal triamcinolone and beclomethasone.

This report will provide a review on the comparative clinical effectiveness and safety between intranasal triamcinolone and beclomethasone. TITLE: Intranasal Triamcinolone versus Intranasal Beclomethasone for Acute and Chronic Sinus Inflammation: A Review of Comparative Clinical Effectiveness and Safety DATE: 29 January 2013 CONTEXT AND POLICY

More information

Effectively Managing Sepsis Denials

Effectively Managing Sepsis Denials Effectively Managing Sepsis Denials Krysten Brooks, RN, BSN, MBA Senior Inpatient Consultant 3M Health Information Systems This is the Full Title of a Session Atlanta, GA 1 Learning Objectives At the completion

More information

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 21, 2019 Report Length: 5 Pages

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 21, 2019 Report Length: 5 Pages CADTH RAPID RESPONSE REPORT: REFERENCE LIST Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines Service Line: Rapid Response Service Version:

More information

Update on Sepsis Diagnosis and Management

Update on Sepsis Diagnosis and Management CHAPTER 12 Update on Sepsis Diagnosis and Management Kevin Alexander, DPM INTRODUCTION Sepsis and septic shock have become a large problem in the health care system that affects at least 1 million people

More information

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015 The TIMES Project: (Time to Initiation of Antibiotic Therapy in Medical Patients Presenting to the Emergency Department with Sepsis) - Preliminary Findings Andrea Blotsky MDCM FRCPC General Internal Medicine,

More information